1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Williams Syndrome: new trials by email Literature Review of Williams Syndrome trials Research Report on Williams Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Buspirone Treatment of Anxiety in Williams Syndrome Buspirone - Williams Syndrome, Anxiety | Phase 4 | Completed | Massachusetts General Hospital | 20 | 2021-08-01 | 2024-12-03 |
| The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome methylphenidate, fluoxetin, risperidone - Velocardiofacial Syndrome, Williams Syndrome | Phase 4 | Recruiting | The Chaim Sheba Medical Center | 400 | 2001-05-01 | 2026-03-18 |
Anxiety Disorders (1) · DiGeorge Syndrome (1) · Fragile X Syndrome (1)
Aortic Stenosis, Supravalvular (2) · Aortic Valve Disease (2) · Aortic Valve Stenosis (2) · Cardiovascular Diseases (2) · Chromosome Disorders (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Heart Diseases (2) · Heart Valve Diseases (2) · Intellectual Disability (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · 22q11 Deletion Syndrome (1)
Buspirone (1) · Fluoxetine (1) · Methylphenidate (1) · Risperidone (1)
Massachusetts General Hospital (1) · The Chaim Sheba Medical Center (1)
Israel (1) · United States (1)
Robyn P Thom, MD (1)